Ceramide profiles in the brain of rats with diabetes induced by streptozotocin

FEBS Journal

Volumn 279, Issue 11, 2012, Pages 1943-1952

  Car, Halina ^a   Zendzian Piotrowska, Małgorzata ^a   Prokopiuk, Sławomir ^a   Fiedorowicz, Anna ^a   Sadowska, Anna ^a   Kurek, Krzysztof ^a   Sawicka, Diana ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

brain; ceramides; diabetes; myriocin; sphingomyelin

Indexed keywords

15 TETRACOSENOIC ACID; ARACHIDIC ACID; ARACHIDONIC ACID; BEHENIC ACID; CERAMIDE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LIGNOCERIC ACID; LINOLEIC ACID; LINOLENIC ACID; MONOUNSATURATED FATTY ACID; MYRISTIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; HYPERGLYCEMIA; LIPID BLOOD LEVEL; LIPID BRAIN LEVEL; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; BRAIN; CERAMIDES; CHROMATOGRAPHY, GAS; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; HYPERGLYCEMIA; MALE; RATS; RATS, WISTAR; SERINE C-PALMITOYLTRANSFERASE; STREPTOZOCIN;

RATTUS;

EID: 84861198371     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08575.x     Document Type: Article

References (60)

1. Kodl CT, &, Seaquist ER, (2008) Cognitive dysfunction and diabetes mellitus. Endocr Rev 29, 494-511. (Pubitemid 351831510)
2. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, &, Bennett DA, (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61, 661-666. (Pubitemid 38637681)
3. Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, &, Jope RS, (2006) Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 55, 3320-3325. (Pubitemid 44923588)
4. Wrighten SA, Piroli GG, Grillo CA, &, Reagan LP, (2009) A look inside the diabetic brain: contributors to diabetes-induced brain aging. Biochim Biophys Acta 1792, 444-453.
5. Marks JL, Porte D Jr, Stahl WL, &, Baskin DG, (1990) Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 127, 3234-3236.
6. Magarinos AM, &, McEwen BS, (2000) Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc Natl Acad Sci USA 97, 11056-11061.
7. Novgorodov SA, &, Gudz TI, (2009) Ceramide and mitochondria in ischemia/reperfusion. J Cardiovasc Pharmacol 53, 198-208.
8. Haughey NJ, Bandaru VV, Bae M, &, Mattson MP, (2010) Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. Biochim Biophys Acta 1801, 878-886.
9. van Blitterswijk WJ, van der Luit AH, Veldman RJ, Verheij M, &, Borst J, (2003) Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J 369, 199-211. (Pubitemid 36174190)
10. Arboleda G, Morales LC, Benítez B, &, Arboleda H, (2009) Regulation of ceramide-induced neuronal death: cell metabolism meets neurodegeneration. Brain Res Rev 59, 333-346.
11. Saito M, Chakraborty G, Mao RF, Wang R, Cooper TB, Vadasz C, &, Saito M, (2007) Ethanol alters lipid profiles and phosphorylation status of AMP-activated protein kinase in the neonatal mouse brain. J Neurochem 103, 1208-1218. (Pubitemid 47568737)
12. Satoi H, Tomimoto H, Ohtani R, Kitano T, Kondo T, Watanabe M, Oka N, Akiguchi I, Furuya S, Hirabayashi Y, et al. (2005) Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis. Neuroscience 130, 657-666. (Pubitemid 39601439)
13. Rotstein NP, Miranda GE, Abrahan CE, &, German OL, (2010) Regulating survival and development in the retina: key roles for simple sphingolipids. J Lipid Res 51, 1247-1262.
14. Cutler RG, Haughey NJ, Tammara A, McArthur JC, Nath A, Reid R, Vargas DL, Pardo CA, &, Mattson MP, (2004) Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology 63, 626-630. (Pubitemid 39100816)
15. Ohtani R, Tomimoto H, Kondo T, Wakita H, Akiguchi I, Shibasaki H, &, Okazaki T, (2004) Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia. Brain Res 1023, 31-40. (Pubitemid 39195331)
16. Harris B, Pereira I, &, Parkin E, (2009) Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein. Brain Res 1296, 203-215.
17. Cordy JM, Hussain I, Dingwall C, Hooper NM, &, Turner AJ, (2003) Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci USA 100, 11735-11740. (Pubitemid 37206004)
18. Gõrska M, Dobrzyń A, Zendzian-Piotrowska M, &, Gõrski J, (2004) Effect of streptozotocin-diabetes on the functioning of the sphingomyelin-signalling pathway in skeletal muscles of the rat. Horm Metab Res 36, 14-21. (Pubitemid 38283188)
19. Adams JM II, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, &, Mandarino LJ, (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53, 25-31. (Pubitemid 38044694)
20. Deevska GM, &, Nikolova-Karakashian MN, (2011) The twists and turns of sphingolipid pathway in glucose regulation. Biochimie 93, 32-38.
21. Suzuki J, Akahane K, Nakamura J, Naruse K, Kamiya H, Himeno T, Nakamura N, Shibata T, Kondo M, Nagasaki H, et al. (2011) Palmitate induces apoptosis in Schwann cells via both ceramide-dependent and independent pathways. Neuroscience 176, 188-198.
22. Chen V, &, Ianuzzo CD, (1982) Dosage effect of streptozotocin on rat tissue enzyme activities and glycogen concentration. Can J Physiol Pharmacol 60, 1251-1256. (Pubitemid 13218548)
23. Adikwu MU, Yoshikawa Y, &, Takada K, (2003) Bioadhesive delivery of metformin using prosopis gum with antidiabetic potential. Biol Pharm Bull 26, 662-666. (Pubitemid 39663559)
24. Straczkowski M, Kowalska I, Baranowski M, Nikolajuk A, Otziomek E, Zabielski P, Adamska A, Blachnio A, Gõrski J, &, Gõrska M, (2007) Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 50, 2366-2373. (Pubitemid 47512392)
25. Zendzian-Piotrowska M, Baranowski M, Zabielski P, &, Gõrski J, (2006) Effects of pioglitazone and high-fat diet on ceramide metabolism in rat skeletal muscles. J Physiol Pharmacol 57, 101-114. (Pubitemid 46548770)
26. Shah C, Yang G, Lee I, Bielawski J, Hannun YA, &, Samad F, (2008) Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem 283, 13538-13548.
27. Samad F, Hester KD, Yang G, Hannun YA, &, Bielawski J, (2006) Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55, 2579-2587. (Pubitemid 44871159)
28. Soeda S, Tsuji Y, Ochiai T, Mishima K, Iwasaki K, Fujiwara M, Yokomatsu T, Murano T, Shibuya S, &, Shimeno H, (2004) Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress. Neurochem Int 45, 619-626. (Pubitemid 38844882)
29. He X, Huang Y, Li B, Gong CX, &, Schuchman EH, (2010) Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging 31, 398-408.
30. Wang G, Silva J, Dasgupta S, &, Bieberich E, (2008) Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes. Glia 56, 449-456. (Pubitemid 351212953)
31. Mielke MM, Bandaru VV, Haughey NJ, Rabins PV, Lyketsos CG, &, Carlson MC, (2010) Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging 31, 17-24.
32. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, &, de la Monte SM, (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9, 13-33.
33. de la Monte SM, Tong M, Nguyen V, Setshedi M, Longato L, &, Wands JR, (2010) Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. J Alzheimers Dis 21, 967-984.
34. Tong M, &, de la Monte SM, (2009) Mechanisms of ceramide-mediated neurodegeneration. J Alzheimers Dis 16, 705-714.
35. Ussher JR, Koves TR, Cadete VJ, Zhang L, Jaswal JS, Swyrd SJ, Lopaschuk DG, Proctor SD, Keung W, Muoio DM, et al. (2010) Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 59, 2453-2464.
36. Johnson VJ, He Q, Osuchowski MF, &, Sharma RP, (2004) Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations. Toxicology 201, 67-75. (Pubitemid 39023934)
37. Osuchowski MF, Johnson VJ, He Q, &, Sharma RP, (2004) Myriocin, a serine palmitoyltransferase inhibitor, alters regional brain neurotransmitter levels without concurrent inhibition of the brain sphingolipid biosynthesis in mice. Toxicol Lett 147, 87-94. (Pubitemid 38045323)
38. Chun J, &, Hartung HP, (2010) Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol 33, 91-101.
39. Wang G, Krishnamurthy K, Chiang YW, Dasgupta S, &, Bieberich E, (2008) Regulation of neural progenitor cell motility by ceramide and potential implications for mouse brain development. J Neurochem 106, 718-733.
40. Miyake Y, Kozutsumi Y, Nakamura S, Fujita T, &, Kawasaki T, (1995) Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun 211, 396-403.
41. Yi SS, Hwang IK, Kim DW, Shin JH, Nam SM, Choi JH, Lee CH, Won MH, Seong JK, &, Yoon YS, (2011) The chronological characteristics of SOD1 activity and inflammatory response in the hippocampi of STZ-induced type 1 diabetic rats. Neurochem Res 36, 117-128.
42. de la Monte SM, Tong M, Lawton M, &, Longato L, (2009) Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment. Mol Neurodegener 4, 54.
43. Lyn-Cook LE Jr, Lawton M, Tong M, Silbermann E, Longato L, Jiao P, Mark P, Wands JR, Xu H, &, de la Monte SM, (2009) Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. J Alzheimers Dis 16, 715-729.
44. Brush RS, Tran JT, Henry KR, McClellan ME, Elliott MH, &, Mandal MN, (2010) Retinal sphingolipids and their very-long-chain fatty acid-containing species. Invest Ophthalmol Vis Sci 51, 4422-4431.
45. He X, Guan XL, Ong WY, Farooqui AA, &, Wenk MR, (2007) Expression, activity, and role of serine palmitoyltransferase in the rat hippocampus after kainate injury. J Neurosci Res 85, 423-432. (Pubitemid 46219310)
46. Ben-David O, &, Futerman AH, (2010) The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases. Neuromolecular Med 12, 341-350.
47. Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, Turchan J, Nath A, &, Mattson MP, (2004) Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol 55, 257-267. (Pubitemid 38167003)
48. Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, &, Mattson MP, (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA 101, 2070-2075. (Pubitemid 38229016)
49. Guan XL, He X, Ong WY, Yeo WK, Shui G, &, Wenk MR, (2006) Non-targeted profiling of lipids during kainate-induced neuronal injury. FASEB J 20, 1152-1161. (Pubitemid 44943911)
50. Tang N, Ong WY, Zhang EM, Chen P, &, Yeo JF, (2007) Differential effects of ceramide species on exocytosis in rat PC12 cells. Exp Brain Res 183, 241-247. (Pubitemid 47497719)
51. Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill AH Jr, &, Futerman AH, (2008) Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem 283, 5677-5684.
52. Adibhatla RM, &, Hatcher JF, (2008) Altered lipid metabolism in brain injury and disorders. Subcell Biochem 49, 241-268.
53. Serhan CN, (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25, 101-137. (Pubitemid 46697904)
54. Brosky G, &, Logothetopoulos J, (1969) Streptozotocin diabetes in the mouse and guinea pig. Diabetes 8, 606-611.
55. Elias D, Prigozin H, Polak N, Rapoport M, Lohse AW, &, Cohen IR, (1994) Autoimmune diabetes induced by the b-cell toxin STZ. Diabetes 43, 992-998.
56. Weiss RB, (1982) Streptozotocin: a review of its pharmacology, efficacy and toxicity. Cancer Treat Rep 66, 427-438. (Pubitemid 12084932)
57. Folch J, Less M, &, Sloane SGH, (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
58. Yano M, Kishida E, Muneyuki Y, &, Masuzawa Y, (1998) Quantitative analysis of ceramide molecular species by high performance liquid chromatography. J Lipid Res 39, 2091-2098. (Pubitemid 28462367)
59. Mahadevappa VG, &, Holub BJ, (1987) Chromatographic analysis of phosphoinositides and their breakdown products in activated blood platelets/neutrophils. In Chromatography of Lipids in Biomedical Research and Clinical Diagnosis (, Kuksis A, ed.), pp. 225-265. Elsevier, Amsterdam.
60. Dobrzyn A, &, Gõrski J, (2002) Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise. Am J Physiol Endocrinol Metab 282, E277-E285. (Pubitemid 34654797)